HQY
Healthequity·NASDAQ
--
--(--)
--
--(--)
HQY fundamentals
Healthequity (HQY) released its earnings on Mar 17, 2026: revenue was 334.60M (YoY +7.31%), beat estimates; EPS was 0.95 (YoY +37.68%), beat estimates.
Revenue / YoY
334.60M
+7.31%
EPS / YoY
0.95
+37.68%
Report date
Mar 17, 2026
HQY Earnings Call Summary for Q4,2026
- Record Growth: 23% EBITDA growth, 500+ basis points margin expansion, and 17.8 million HSA accounts highlight FY2026 success.
- AI-Driven Efficiency: Fraud costs reduced to 0.1 basis points, service automation cutting costs 5% YoY.
- Marketplace Expansion: Early adoption of health services marketplace shows 100+ billion market opportunity.
- ACA Tailwind: Bronze plan HSA eligibility adds 10%+ market expansion, with early sales momentum.
- FY2027 Guidance: $1.41B revenue, 38% EPS growth, and 20% EBITDA expansion reflect confidence in AI, engagement, and ACA growth.
EPS
Actual | 0.39 | 0.43 | 0.42 | 0.41 | 0.42 | 0.38 | 0.4 | 0.35 | 0.2 | 0.27 | 0.33 | 0.38 | 0.37 | 0.5 | 0.53 | 0.6 | 0.63 | 0.8 | 0.86 | 0.78 | 0.69 | 0.97 | 1.08 | 1.01 | 0.95 | ||||||||||
Forecast | 0.3511 | 0.4356 | 0.2741 | 0.3584 | 0.4047 | 0.3235 | 0.3628 | 0.3468 | 0.2146 | 0.26 | 0.3302 | 0.3466 | 0.3492 | 0.4053 | 0.477 | 0.4999 | 0.5679 | 0.6564 | 0.699 | 0.7223 | 0.716 | 0.8128 | 0.9142 | 0.9123 | 0.8977 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +11.08% | -1.29% | +53.23% | +14.40% | +3.78% | +17.47% | +10.25% | +0.92% | -6.80% | +3.85% | -0.06% | +9.64% | +5.96% | +23.37% | +11.11% | +20.02% | +10.94% | +21.88% | +23.03% | +7.99% | -3.63% | +19.34% | +18.14% | +10.71% | +5.83% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 201.20M | 190.01M | 176.04M | 179.35M | 188.17M | 184.20M | 189.10M | 179.95M | 203.30M | 205.68M | 206.14M | 216.09M | 233.84M | 244.43M | 243.55M | 249.20M | 262.40M | 287.60M | 299.93M | 300.40M | 311.80M | 330.80M | 325.80M | 322.20M | 334.60M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 199.31M | 193.72M | 171.28M | 176.82M | 185.78M | 181.20M | 185.09M | 183.97M | 199.88M | 203.98M | 203.88M | 206.79M | 230.73M | 239.39M | 239.96M | 243.61M | 258.69M | 277.91M | 285.13M | 290.09M | 305.82M | 322.28M | 320.74M | 320.63M | 332.32M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +0.95% | -1.92% | +2.78% | +1.43% | +1.28% | +1.66% | +2.17% | -2.18% | +1.71% | +0.83% | +1.11% | +4.50% | +1.35% | +2.11% | +1.49% | +2.30% | +1.43% | +3.49% | +5.19% | +3.55% | +1.95% | +2.64% | +1.58% | +0.49% | +0.69% |
Earnings Call
You can ask Aime
What guidance did Healthequity's management provide for the next earnings period?What is the market's earnings forecast for Healthequity next quarter?What were the key takeaways from Healthequity's earnings call?What factors drove the changes in Healthequity's revenue and profit?Did Healthequity beat or miss consensus estimates last quarter?What is Healthequity's gross profit margin?What is the revenue and EPS growth rate for Healthequity year over year?What does Healthequity do and what are its main business segments?
